| Institution | Location | Analyst | Rating | latest publication |
| Baader Bank | Munich | Karin Brinkmann | Buy | 30 Jan 12 |
| Bankhaus Lampe | Düsseldorf | Marc Gabriel | Hold | 30 Jan 12 |
| Bank of America Merrill Lynch | London | 1 | 1 | 17 May 10 |
| Bayerische Landesbank | Munich | 2 | Buy | 04 Oct 11 |
| Berenberg Bank | Hamburg | 1 | 1 | 24 Feb 10 |
| BHF Bank | Frankfurt | Jens Jung | Restricted 3 | 22 Sep 10 |
| CA Cheuvreux | Frankfurt | Borja Castro | Underperform | 05 Jan 12 |
| Citi | London | 1 | 1 | 07 Dec 11 |
| Commerzbank | Frankfurt | Norbert Kretlow | Hold | 30 Jan 12 |
| Deutsche Bank | Frankfurt | Michael Kuhn | Restricted 3 | 17 Sep 10 |
| DZ Bank | Frankfurt | Marc Nettelbeck | Buy | 31 Jan 12 |
| equinet | Frankfurt | Ingbert Faust | Buy | 30 Jan 12 |
| Goldman Sachs | London | Will Morgan | Buy | 31 Jan 12 |
| Hamburger Sparkasse | Hamburg | Ingo Schmidt | Hold | 05 Dec 11 |
| Hauck & Aufhäuser | Hamburg | 2 | Buy | 04 Oct 11 |
| HSBC Trinkaus & Burkhardt | Düsseldorf | Thomas Teetz | Neutral | 09 Dec 11 |
| Independent Research | Frankfurt | Stefan Röhle | Hold | 04 Oct 11 |
| Kepler Capital Markets | Frankfurt | 1 | 1 | 14 Nov 11 |
| Landesbank Baden-Württemberg | Stuttgart | Hans-Peter Kuhlmann | Hold | 30 Jan 12 |
| Landesbank Berlin | Berlin | 4 | Hold | 19 Aug 11 |
| MainFirst Bank | Frankfurt | Christian Korth | Buy | 30 Jan 12 |
| M.M. Warburg & Co | Hamburg | Frank Laser | Buy | 30 Jan 12 |
| National-Bank | Essen | Steffen Manske | Hold | 14 Nov 11 |
| NordLB | Hannover | Heino Hammann | Hold | 15 Nov 11 |
| Société Générale | Madrid | Victor Acitores | Buy | 04 Jan 12 |
| Standard & Poor's | London | Jawahar Hingorani | Hold | 30 Jan 12 |
| UBS | London | Gregor Kuglitsch | Neutral | 31 Jan 12 |
| WestLB | Düsseldorf | Ralf Dörper | Buy | 09 Jan 12 |
| WGZ Bank AG | Düsseldorf | 2 | Sell | 03 Feb 12 |
1 Change of analyst
2 through external Research Insitute
3 restricted since acting as financial advisor
4 cooperation with NordLB
Disclaimer
The research reports and other analysts' statements referred to here have been
received from third parties, in particular from equity and credit analysts
employed by a range of banks and investment banks. Reference to such reports and
statements is provided for information only and does not imply any agreement
with or consent to the content of such reports and statements or the
information, opinions or conclusions contained therein. HOCHTIEF further draws
attention to the disclaimers issued by each firm whose reports and statements
are referred to here, which should be read in full. HOCHTIEF accepts no
liability for the selection, current relevance, completeness or correctness of
the analysts' recommendations or assessments referred to here. None of the
information contained or referred to on this Internet site is to be understood
as an offer for purchase of shares or bonds of HOCHTIEF or its subsidiaries or
related undertakings. Any liability on the part of HOCHTIEF Aktiengesellschaft
for losses incurred by third parties arising from the research reports and other
analysts' statements contained or referred to on this website is precluded.
| 2012 |
| January |
| February |
| March |
| April |
| May |
| June |
| July |
| August |
| September |
| October |
| November |
| December |
| 2011 |
| 2010 |
| 2009 |
| 2008 |
| 2007 |
| 2006 |
| 2005 |
| 2004 |
| Date of publication | Institution | Rating |
| 03 Feb 12 | WGZ Bank | Sell |
Disclaimer
The research reports and other analysts' statements referred to here have been
received from third parties, in particular from equity and credit analysts
employed by a range of banks and investment banks. Reference to such reports and
statements is provided for information only and does not imply any agreement
with or consent to the content of such reports and statements or the
information, opinions or conclusions contained therein. HOCHTIEF further draws
attention to the disclaimers issued by each firm whose reports and statements
are referred to here, which should be read in full. HOCHTIEF accepts no
liability for the selection, current relevance, completeness or correctness of
the analysts' recommendations or assessments referred to here. None of the
information contained or referred to on this Internet site is to be understood
as an offer for purchase of shares or bonds of HOCHTIEF or its subsidiaries or
related undertakings. Any liability on the part of HOCHTIEF Aktiengesellschaft
for losses incurred by third parties arising from the research reports and other
analysts' statements contained or referred to on this website is precluded.
| positive | 9 (47.4%) | |
| neutral | 9 (47.4%) | |
| negative | 1 (5.3%) | |
positive: accumulate, add, buy, outperform, etc.
neutral: hold, neutral, market perform, etc.
negative: reduce, sell, underperform, etc.
As of January 16, 2012
* Publication of Interim Report January-September 2011
Disclaimer
The research reports and other analysts' statements referred to here have been
received from third parties, in particular from equity and credit analysts
employed by a range of banks and investment banks. Reference to such reports and
statements is provided for information only and does not imply any agreement
with or consent to the content of such reports and statements or the
information, opinions or conclusions contained therein. HOCHTIEF further draws
attention to the disclaimers issued by each firm whose reports and statements
are referred to here, which should be read in full. HOCHTIEF accepts no
liability for the selection, current relevance, completeness or correctness of
the analysts' recommendations or assessments referred to here. None of the
information contained or referred to on this Internet site is to be understood
as an offer for purchase of shares or bonds of HOCHTIEF or its subsidiaries or
related undertakings. Any liability on the part of HOCHTIEF Aktiengesellschaft
for losses incurred by third parties arising from the research reports and other
analysts' statements contained or referred to on this website is precluded.
| Minimum | 42.00 |
| Average | 54.27 |
| Median | 54.95 |
| Maximum | 70.00 |
| Sales (EUR million) | ||||
| Minimum | Average | Median | Maximum | |
| 2011 | 19,978 | 21,266 | 21,173 | 22,881 |
| EBT (EUR million) | ||||
| Minimum | Average | Median | Maximum | |
| 2011 | -108 | -21 | -41 | 360 |
| Net income (EUR million) | ||||
| Minimum | Average | Median | Maximum | |
| 2011 | -128 | -64 | -98 | 250 |
| Earnings per share (EUR) ¹ | ||||
| Minimum | Average | Median | Maximum | |
| 2011 | -1.74 | -0.87 | -1.33 | 3.40 |
| Dividend per share (EUR) ² | ||||
| Minimum | Average | Median | Maximum | |
| 2011 | 0.00 | 0.70 | 0.10 | 2.00 |
As of January 16, 2012
* Publication of Interim Report January-September 2011
¹ based on the number of shares in circulation (77 million shares minus own shares)
² based on the number of shares issued (77 million shares)
Disclaimer
The research reports and other analysts' statements referred to here have been
received from third parties, in particular from equity and credit analysts
employed by a range of banks and investment banks. Reference to such reports and
statements is provided for information only and does not imply any agreement
with or consent to the content of such reports and statements or the
information, opinions or conclusions contained therein. HOCHTIEF further draws
attention to the disclaimers issued by each firm whose reports and statements
are referred to here, which should be read in full. HOCHTIEF accepts no
liability for the selection, current relevance, completeness or correctness of
the analysts' recommendations or assessments referred to here. None of the
information contained or referred to on this Internet site is to be understood
as an offer for purchase of shares or bonds of HOCHTIEF or its subsidiaries or
related undertakings. Any liability on the part of HOCHTIEF Aktiengesellschaft
for losses incurred by third parties arising from the research reports and other
analysts' statements contained or referred to on this website is precluded.